Initiating Mixtard in High Hyperglycemia
Start Mixtard at 0.3-0.5 units/kg/day divided as two-thirds in the morning and one-third in the evening, with the morning dose given 30 minutes before breakfast and the evening dose before dinner, titrating by 2-4 units every 3 days based on fasting and pre-dinner glucose levels. 1
Initial Dosing Strategy
For insulin-naive patients with severe hyperglycemia (glucose >300 mg/dL or HbA1c >10%), begin with 0.4-0.5 units/kg/day total daily dose. 1, 2
- Calculate total daily dose: For a 70 kg patient, this equals 28-35 units/day 2
- Distribute as 2/3 of total dose in the morning (approximately 20-24 units) and 1/3 in the evening (approximately 10-12 units) 1, 2
- Administer morning dose 30 minutes before breakfast to allow the regular insulin component to align with postprandial glucose rise 3, 2
- Give evening dose 30 minutes before dinner 2
Titration Protocol
Increase doses by 2-4 units every 3 days based on glucose patterns, targeting fasting glucose 80-130 mg/dL and pre-dinner glucose <180 mg/dL. 1
- If fasting glucose remains >150 mg/dL, increase the evening dose by 2-4 units 1, 4
- If pre-dinner glucose is elevated, increase the morning dose by 2-4 units 1
- Monitor for hypoglycemia during titration, particularly nocturnal hypoglycemia with NPH-containing formulations like Mixtard 1, 5
Critical Monitoring Requirements
Check fasting and pre-dinner glucose daily during the first 2 weeks of titration. 1, 2
- Perform blood glucose monitoring before each meal and at bedtime initially 1, 2
- Add 2-hour postprandial checks if HbA1c remains >7.5% despite adequate fasting control 2
- Reassess HbA1c every 3 months 6
- Track all hypoglycemic episodes (glucose ≤70 mg/dL) 1, 5
Patient Education Essentials
Provide "survival skills" education covering injection technique, timing relative to meals, hypoglycemia recognition and treatment, and sick day management before hospital discharge. 1, 2
- Teach proper injection technique using 4-6 mm needles to avoid intramuscular injection 2
- Emphasize site rotation to prevent lipohypertrophy, which distorts insulin absorption 2
- Instruct on treating hypoglycemia with 15-20 grams of fast-acting carbohydrate 5
- Explain that insulin doses must be adjusted during acute illness 1
When to Consider Alternative Approaches
If the patient has cardiovascular disease, heart failure, or chronic kidney disease, strongly consider adding a GLP-1 receptor agonist before or alongside insulin initiation to provide cardiorenal protection beyond glucose lowering. 1, 7
- GLP-1 RAs reduce hypoglycemia risk and weight gain compared to insulin intensification alone 1
- They allow lower insulin doses to achieve the same glycemic targets 1, 7
- Consider fixed-ratio combinations of basal insulin with GLP-1 RA if available and affordable 1
Common Pitfalls to Avoid
Do not use sliding-scale insulin as monotherapy—it is ineffective and increases hypoglycemia risk. 1, 4
- Avoid delaying insulin initiation when glucose consistently exceeds 300 mg/dL, as prolonged severe hyperglycemia causes irreversible complications 7
- Do not continue ineffective oral therapy for months hoping for spontaneous improvement 7
- Never inject into areas of lipohypertrophy, as this causes erratic absorption 2
- Do not abruptly discontinue metformin when starting insulin, as the combination reduces weight gain and insulin requirements 2
Special Circumstances Requiring Modification
In patients receiving glucocorticoids, increase the morning Mixtard dose by 50-100% to cover daytime hyperglycemia, as steroids cause disproportionate afternoon and evening glucose elevation. 1
- For dexamethasone specifically, consider switching to NPH twice daily at 0.3 units/kg/day total (2/3 morning, 1/3 evening) for easier dose adjustment 1
- Reduce insulin doses rapidly when steroids are discontinued to prevent severe hypoglycemia 1
For hospitalized patients on enteral nutrition, switch from Mixtard to NPH every 8-12 hours with correctional rapid-acting insulin every 4-6 hours, as continuous feeding requires different insulin coverage. 1